Senseonics Holdings Inc., a medical technology company specializing in long-term implantable continuous glucose monitoring systems, has announced it will transfer its common stock listing from the NYSE American to the Nasdaq Global Select Market. The transition is scheduled to take effect after the market closes on November 14, 2025. Trading on Nasdaq under the existing ticker symbol "SENS" is expected to begin on November 17, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Senseonics Holdings Inc. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.